Market revenue in 2023 | USD 1,055.1 million |
Market revenue in 2030 | USD 1,625.1 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.64% in 2023. Horizon Databook has segmented the India breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
In India, rise in urbanization and adoption of western lifestyle have resulted in increased incidence of breast cancer. According to NCBI, in 2017, mortality due to breast cancer was 12.7 per 100,000 women, and incidence of breast cancer was 25.8 per 100,000 women in India. According to the statistics published in India Against Cancer report, 1 in every 2 women in India newly diagnosed with this cancer dies.
However, this also creates growth opportunities for novel and highly efficient diagnostics in the market. The Indian market has different scenario compared to other Asia Pacific countries such as Japan and China, owing to more relaxed regulatory guidelines and import of most kits & instruments from other countries.
The market in the country is expected to witness significant growth owing to increased investment by private and foreign entities, which can help provide effective tests at lower costs. This further improves the scope of breast cancer diagnostics market in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into India breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account